605507.SS Live signals | Maximize Profits with Getagraph.com

Live Chart Being Loaded With Signals

Commentary (25 Apr 2024 @ 03:00):

Guobang Pharma Ltd. engages in the research and development, production, and sale of medical products for human and animals in China. It offers medical products, including APIs, medication intermediates related to the API, and formulations; and veterinary products, such as APIs for animals, additives, and formulations...

Stats
Today's Volume	4.97M
Average Volume	3.73M
Market Cap	9.05B
EPS	CNY0.239 ( 2023-10-18 )
Last Dividend	CNY0 ( N/A )
Next Dividend	CNY0 ( N/A )
P/E	14.59
ATR14	CNY0.0110 (0.07%)

Volume Correlation

Long: -0.09 (neutral)

Short: 0.72 (moderate)

Signal:(45.235) Neutral

Guobang Pharma Ltd. Correlation

10 Most Positive Correlations

10 Most Negative Correlations

Did You Know?

Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).

Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.

Guobang Pharma Ltd. Correlation - Currency/Commodity

0.46
( neutral )

0.31
( neutral )

0.00
( neutral )

-0.05
( neutral )

-0.12
( neutral )

0.07
( neutral )

Guobang Pharma Ltd. Financials

Annual	2023
Revenue:	CNY5.35B
Gross Profit:	CNY1.25B (23.41 %)
EPS:	CNY1.100

Q1	2024
Revenue:	CNY1.34B
Gross Profit:	CNY367.24M (27.43 %)
EPS:	CNY0.360

Q4	2023
Revenue:	CNY1.30B
Gross Profit:	CNY253.02M (19.52 %)
EPS:	CNY0.220

Q3	2023
Revenue:	CNY1.24B
Gross Profit:	CNY307.06M (24.69 %)
EPS:	CNY0.240

Financial Reports:

No articles found.

Guobang Pharma Ltd.